More on ACIU
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.73 |
|
|||
| Open | $2.73 | ||||
| 52 Wk High | $19.97 | ||||
| 52 Wk Low | $10.36 | ||||
| Day High | $2.82 | ||||
| Day Low | $2.66 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 211,064 | ||||
- AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
- Form 6-K AC Immune SA For: Feb 24
- AC Immune begins phase 1 trial of brain-penetrant inflammation drug
- AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
- Form 6-K AC Immune SA For: Feb 17
- Form 144 AC Immune SA Filed by: Pfeifer Andrea
- Form 6-K AC Immune SA For: Dec 11
- AC Immune reports positive interim phase 2 results for Parkinson's drug
- AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease
- AC Immune to Present at the Jefferies 2025 London Healthcare Conference
Entities mentioned with ACIU
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Jefferies & Co | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- UBS | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
